Teglicar
Teglicar is a selective and reversible orally active liver isoform of carnitine palmitoyl-transferase 1 (L-CPT1) inhibitor with an IC50 value of 0.68 μM and a Ki value of 0.36 μM. Teglicar has a potential antihyperglycemic propert. Teglicar can be used for the research of diabetes and neurodegenerative disease including Huntington's disease (HD) [1][2].
Product Specifications
CAS Number
250694-07-6
UNSPSC
12352211
Target
Endogenous Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/teglicar.html
Purity
98.0
Solubility
DMSO : 19 mg/mL (ultrasonic) |Ethanol : 100 mg/mL (ultrasonic; heat to 60°C) |H2O : 10 mg/mL (ultrasonic)
Smiles
O=C(N[C@H](CC([O-])=O)C[N+](C)(C)C)NCCCCCCCCCCCCCC
Molecular Formula
C22H45N3O3
Molecular Weight
399.61
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Alkaline Phosphatase (ALPL/597), CF640R conjugate, 0.1mg/mL
